Polymorphism in Vitamin D receptors linked to development of vitiligo
Written By : Jacinthlyn Sylvia
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2022-11-11 14:30 GMT | Update On 2022-11-11 14:30 GMT
Advertisement
In a new study published in Journal of Cosmetic Dermatology, it was shown that ApaI and BsmI polymorphisms in vitamin D receptor (VDR) have been linked to vitiligo susceptibility in the Asian population.
The susceptibility to vitiligo may be significantly influenced by polymorphisms in the vitamin D receptor. Numerous research studies have examined the links between Vitamin D receptor (VDR) polymorphisms and the chance of developing vitiligo, although the results are still controversial. In order to ascertain if polymorphisms in the VDR are related to the susceptibility to vitiligo, Young Ho Lee and colleagues carried out this investigation.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.